4/A

PRIMARY DOCUMENT

Company: UNITED THERAPEUTICS Corp
Filed: June 14, 2012
Period of Report: June 11, 2012
Accession Number: 0001127602-12-020086

View Document ↗ View on SEC.gov ↗